Literature DB >> 27217211

Early GABAergic transmission defects in the external globus pallidus and rest/activity rhythm alteration in a mouse model of Huntington's disease.

Zhuowei Du1, Marine Chazalon2, Emma Bestaven1, Thierry Leste-Lasserre3, Jérôme Baufreton2, Jean-René Cazalets1, Yoon H Cho1, Maurice Garret4.   

Abstract

Huntington's disease (HD) is characterized by progressive motor symptoms preceded by cognitive deficits and is regarded as a disorder that primarily affects the basal ganglia. The external globus pallidus (GPe) has a central role in the basal ganglia, projects directly to the cortex, and is majorly modulated by GABA. To gain a better understanding of the time course of HD progression and gain insight into the underlying mechanisms, we analyzed GABAergic neurotransmission in the GPe of the R6/1 mouse model at purportedly asymptomatic and symptomatic stages (i.e., 2 and 6months). Western blot and quantitative polymerase chain reaction (PCR) analyses revealed alterations in the GPe of male R6/1 mice compared with wild-type littermates. Expression of proteins involved in pre- and post-synaptic GABAergic compartments as well as synapse number were severely decreased at 2 and 6months. At both ages, patch-clamp electrophysiological recordings showed a decrease of spontaneous and miniature inhibitory post-synaptic currents (IPSCs) suggesting that HD mutation has an early effect on the GABA signaling in the brain. Therefore, we performed continuous locomotor activity recordings from 2 to 4months of age. Actigraphy analyses revealed rest/activity fragmentation alterations that parallel GABAergic system impairment at 2months, while the locomotor deficit is evident only at 3months in R6/1 mice. Our results reveal early deficits in HD and support growing evidence for a critical role played by the GPe in physiological and pathophysiological states. We suggest that actimetry may be used as a non-invasive tool to monitor early disease progression.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  basal ganglia; disease progression; inhibitory post-synaptic currents; locomotor activity; rest/activity fragmentation; synapse

Mesh:

Substances:

Year:  2016        PMID: 27217211     DOI: 10.1016/j.neuroscience.2016.05.027

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

Review 1.  Gephyrin: a key regulatory protein of inhibitory synapses and beyond.

Authors:  Femke L Groeneweg; Christa Trattnig; Jochen Kuhse; Ralph A Nawrotzki; Joachim Kirsch
Journal:  Histochem Cell Biol       Date:  2018-09-27       Impact factor: 4.304

Review 2.  Alteration of GABAergic neurotransmission in Huntington's disease.

Authors:  Maurice Garret; Zhuowei Du; Marine Chazalon; Yoon H Cho; Jérôme Baufreton
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

3.  Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease.

Authors:  Magali Cabanas; Cristiana Pistono; Laura Puygrenier; Divyangana Rakesh; Yannick Jeantet; Maurice Garret; Yoon H Cho
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

4.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

5.  Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.

Authors:  Joshua Barry; Garnik Akopian; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci       Date:  2018-04-24       Impact factor: 6.167

6.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

7.  Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease.

Authors:  Magali Cabanas; Fares Bassil; Nicole Mons; Maurice Garret; Yoon H Cho
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

8.  Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.

Authors:  Yunping Deng; Hongbing Wang; Marion Joni; Radhika Sekhri; Anton Reiner
Journal:  J Comp Neurol       Date:  2020-09-20       Impact factor: 3.215

9.  Mechanisms underlying the enhancement of γ-aminobutyric acid responses in the external globus pallidus of R6/2 Huntington's disease model mice.

Authors:  Joshua Barry; Theodore A Sarafian; Joseph B Watson; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci Res       Date:  2020-08-27       Impact factor: 4.433

10.  Differential Alteration in Expression of Striatal GABAAR Subunits in Mouse Models of Huntington's Disease.

Authors:  Zhuowei Du; Margot Tertrais; Gilles Courtand; Thierry Leste-Lasserre; Laura Cardoit; Frédérique Masmejean; Christophe Halgand; Yoon H Cho; Maurice Garret
Journal:  Front Mol Neurosci       Date:  2017-06-20       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.